• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

VIRP:FP

153.0500 EUR 1.3000 0.84%

As of 11:35:00 ET on 08/20/2014.

Snapshot for Virbac SA (VIRP)

Open: 153.6000 Day's Range: 152.0500 - 154.5000 Volume: 832
Previous Close: 154.3500 52wk Range: 136.2000 - 184.1000 1-Yr Rtn: +4.41%

Stock Chart for VIRP

No chart data available.
  • VIRP:FP 153.0500
  • 1D
  • 1M
  • 1Y
154.3500
Interactive VIRP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VIRP

Current P/E Ratio (ttm) 21.3162
Estimated P/E(12/2014) 20.1647
Relative P/E vs. CAC 0.8424
Earnings Per Share (EUR) (ttm) 7.1800
Est. EPS (EUR) (12/2014) 7.5900
Est. PEG Ratio -
Market Cap (M EUR) 1,294.50
Shares Outstanding (M) 8.46
30 Day Average Volume 2,309
Price/Book (mrq) 3.5866
Price/Sale (ttm) 1.7523
Dividend Indicated Gross Yield 1.24%
Cash Dividend (EUR) 1.9000
Dividend Ex-Date 06/20/2014
5 Year Dividend Growth 9.63%
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VIRP

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for VIRP

Virbac SA manufactures antibiotics, worm medicines, and vaccines for veterinary use. The Company's products are distributed in the United States, Europe, Asia and South America.

Eric MareeChairman-Mgmt BoardMichel GaraudetChief Financial Officer
Christian KarstExec VP:Corporate DevSebastien HuronDir:Commercial Ops
More Company Profile & Key Executives for VIRP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil